Abstract:Alzheimer's disease is a progressive neurodegenerative disorder characterized histologically in postmortem human brains by the presence of dense protein accumulations known as amyloid plaques and tau tangles. Plaques and tangles develop over decades of aberrant protein processing, post-translational modification, and misfolding throughout an individual's lifetime. We present a foundation of evidence from the literature that suggests chronic stress is associated with increased disease severity in Alzheimer's patient populations. Taken together with preclinical evidence that chronic stress signaling can precipitate cellular distress, we argue that chronic psychological stress renders select circuits more vulnerable to amyloid- and tau- related abnormalities. We discuss the ongoing investigation of systemic and cellular processes that maintain the integrity of protein homeostasis in health and in degenerative conditions such as Alzheimer's disease that have revealed multiple potential therapeutic avenues. For example, the endogenous cannabinoid system traverses the central and peripheral neural systems while simultaneously exerting anti-inflammatory influence over the immune response in the brain and throughout the body. Moreover, the cannabinoid system converges on several stress-integrative neuronal circuits and critical regions of the hypothalamic-pituitary-adrenal axis, with the capacity to dampen responses to psychological and cellular stress. Targeting the cannabinoid system by influencing endogenous processes or exogenously stimulating cannabinoid receptors with natural or synthetic cannabis compounds has been identified as a promising route for Alzheimer's Disease intervention. We build on our foundational framework focusing on the significance of chronic psychological and cellular stress on the development of Alzheimer's neuropathology by integrating literature on cannabinoid function and dysfunction within Alzheimer's Disease and conclude with remarks on optimal strategies for treatment potential.

Research progress of integrated stress response in pathogenesis of Alzheimer's disease

Effect of intraperitoneal pentobarbital injection or isoflurane inhalation anesthesia on the rat acute stress response

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

The Neuro-Inflammatory Microenvironment: an Important Regulator of Stem Cell Survival in Alzheimer’s Disease

Molecular Mechanisms of ER Stress and UPR in the Pathogenesis of Alzheimer’s Disease

Mammalian integrated stress responses in stressed organelles and their functions

Inhibition of the ISR abrogates mGluR5-dependent long-term depression and spatial memory deficits in a rat model of Alzheimer’s disease

Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer's disease

The integrated stress response in ischemic diseases

Research Progress on Alzheimer's Disease and Resveratrol

Quercetin Regulates the Integrated Stress Response to Improve Memory

The Neuro-Inflammatory Microenvironment: An Important Regulator of Stem Cell Survival in Alzheimer's Disease

Endoplasmic reticulum stress in Alzheimer's disease: Molecular mechanisms and therapeutic prospects

The Regulation of Integrated Stress Response Signaling Pathway on Viral Infection and Viral Antagonism

Research progress of inflammation reaction related to endoplasmic reticulum stress in ischemic endoplasmic reticulum stress

The integrated stress response: From mechanism to disease

Aging as a Precipitating Factor in Chronic Restraint Stress-Induced Tau Aggregation Pathology, and the Protective Effects of Rosmarinic Acid

Oxidative stress in Alzheimer's disease: current knowledge of signaling pathways and therapeutics

Stress Regulates Alzheimer’s Disease Progression Via Selective Enrichment of CD8+ T Cells

ER Stress and UPR in Alzheimer’s Disease: Mechanisms, Pathogenesis, Treatments

Integrating Stress Responses and Immunity